New York Times (January 27)
“For months now, wealthy countries have been clearing the world’s shelves of coronavirus vaccines, leaving poorer nations with little hope of exiting the pandemic in 2021. But a fresh skirmish this week has pitted the rich against the rich — Britain versus the European Union — in the scramble for vials, opening a new and unabashedly nationalist competition that could poison relations and set back collective efforts to end the pandemic.”
Tags: Collective efforts, Competition, Coronavirus, EU, Nationalist, Nations, Pandemic, Poison, Poor, Relations, Rich, Skirmish, UK, Vaccines, Wealthy
New York Times (December 18)
“Rising Covid-19 cases are taking a steep toll on economic activity, battering the labor market even as new vaccines offer a ray of hope for next year.” After dropping earlier in autumn, jobless claims “have moved higher, and they remain at levels that dwarf the pace of past recessions.” New restrictions are hammering “the hospitality industry, lodging, airlines and other service businesses…. Until mass inoculations begin next year, the economy will remain under pressure.”
Tags: Airlines, Battering, COVID-19, Economic activity, Hope, Hospitality, Jobless claims, Labor market, Lodging, Recessions, Restrictions, Toll, Vaccines
Los Angeles Times (November 27)
“A lack of data hides the pandemic’s true toll on American main Streets because many small businesses simply board up without going through Bankruptcy Court.” Vaccines promise hope, but more immediately these businesses face uncertainty and hardship. “As virus cases soar, small businesses at the heart of communities ponder their survival.”
Tags: Bankruptcy Court, Data, Hardship, Hope, Pandemic, Small businesses, Survival, Toll, Uncertainty, Vaccines, Virus
Denver Post (October 20)
“Poor people around the world who were among the hardest hit by the virus pandemic are also likely to be the last to recover from it.” The vaccines showing the most promise “need nonstop sterile refrigeration to stay potent and safe.” This isn’t available for over a third of the population. “Nearly 3 billion of the world’s 7.8 billion people live where temperature-controlled storage is insufficient for an immunization campaign to bring COVID-19 under control.”
Tags: COVID-19, Immunization, Pandemic, Poor, Population, Potent, Recover, Refrigeration, Safe, Sterile, Storage, Temperature, Vaccines
Wall Street Journal (May 15)
“It is always hard anticipating successful drugs, but those wagering on coronavirus treatments face unique challenges. Some of the most innovative and promising approaches are wholly unproven. Companies are competing with foreign nations and not-for-profit organizations determined to achieve their own breakthroughs. Successful drugs or vaccines may run into pricing, manufacturing and distribution difficulties.” Issues like these explain why “big investors aren’t betting it all on a coronavirus cure.”
Tags: Breakthroughs, Challenges, Coronavirus, Distribution, Drugs, Innovative, Manufacturing, NPOs, Pricing, Unproven, Vaccines
